DOJ recently formed the Antitrust Division’s (the “Division”) Task Force on Health Care Monopolies and Collusion (“HCMC”), signaling anticompetitive activity in health care markets as an enforcement priority....more
9/6/2024
/ Anti-Competitive ,
Antitrust Division ,
Collusion ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Federal Trade Commission (FTC) ,
Health Care Providers ,
Healthcare ,
Monopolization ,
Pharmacy Benefit Manager (PBM) ,
Public Comment ,
Request For Information ,
Unfair or Deceptive Trade Practices
Without stable housing, recovery for substance use disorder is nearly impossible. “Recovery housing” (or more commonly referred to as a “sober home” or a “sober living residence”) is a broad term that describes a safe,...more
Employers must check its employees, contractors and vendors to see if an individual or organization is excluded from participating in federal and/or state programs. While there are a variety of exclusion programs at the...more
6/10/2024
/ Affordable Care Act ,
Children's Health Insurance Program (CHIP) ,
Department of Health and Human Services (HHS) ,
Employees ,
Employer Liability Issues ,
Exclusions ,
False Claims Act (FCA) ,
Healthcare ,
Healthcare Fraud ,
List of Excluded Individuals/Entities (LEIE) ,
Medicaid ,
Medicare ,
OIG
On April 16, 2024, the U.S. Department of Health and Human Services (HHS) finalized a rule modifying the Confidentiality of Substance Use Disorder (SUD) Patient Records (the Final Rule) codified at 42 C.F.R. Part 2 (Part 2)....more
5/24/2024
/ Confidential Information ,
Consent Order ,
Data Privacy ,
Department of Health and Human Services (HHS) ,
Drug & Alcohol Abuse ,
Final Rules ,
Health Insurance Portability and Accountability Act (HIPAA) ,
HITECH Act ,
Medical Records ,
New Rules ,
Substance Abuse